THE NATIONAL INSTITUTE FOR HEALTH RESEARCH
The NIHR's Health Technology Assessment programme is the largest single national research programme for the NHS. It produces independent research information on the effectiveness, costs and broader impact of healthcare treatments and tests for those who plan, provide or receive care in the NHS. The October-November research grants awards are listed here:
Award winner: Ian Goodyer
Institution: University of Cambridge
Value: £2,406,538
Randomised controlled trial of brief psychodynamic psychotherapy, cognitive behaviour therapy and treatment as usual in adolescents with moderate to severe depression attending routine child and adolescent mental health clinics
Award winner: Ann Netten
Institution: University of Kent at Canterbury
Value: £448,693
Outcomes of social care for adults: developing a preference weighted measure
Award winner: Mark Kilby
Institution: University of Birmingham
Value: £1,024,815
The PLUTO Trial: percutaneous shunting in lower urinary tract obstruction
Award winner: Aziz Sheikh
Institution: University of Edinburgh
Value: £293,717
Modifying health promotion interventions to meet the needs of ethnic minority groups
Award winner: Sallie Lamb
Institution: University of Warwick
Value: £953,700
Strengthening and stretching for people with rheumatoid arthritis of the hands: the clinical and cost-effectiveness of an exercise programme over and above usual care
BREAST CANCER CAMPAIGN
The Breast Cancer Campaign funds research to understand how breast cancer develops. Recent grant winners are below and the remainder will be published in due course.
Award winner: Nicola Brown
Institution: University of Sheffield
Value: £113,635
Bevacizumab response in breast cancer: are neuropilins the key?
Award winner: Kairbaan Hodivala-Dilke
Institution: Barts and the London Queen Mary's School of Medicine and Dentistry
Value: £200,577
Understanding the ribosomal protein L29 (RPL29) in breast cancer angiogenesis
Award winner: Anne Ridley
Institution: King's College London
Value: £196,801
Identification of regulators of breast cancer cell invasion and migration
Award winner: Claire Perks
Institution: University of Bristol
Value: £195,795
IGFBP-2, a novel regulator of PTEN: understanding its role in breast cancer
Award winner: Trevor Dale
Institution: Cardiff University
Value: £198,643
Defining the role of Wnt signalling in mammary stem cells
Award winner: Alan Pockley
Institution: University of Sheffield
Value: £168,616
Hsp70, the breast tumour microenvironment and immunoregulatory T-cells
Award winner: William Newman
Institution: University of Manchester
Value: £105,977
Pharmacogenetics of aromatase inhibitors in breast cancer
Award winner: John Marshall
Institution: Barts and the London Queen Mary's School of Medicine and Dentistry
Value: £183,7
Effects of integrin (alpha)v(beta)6 expression on HER2-dependent breast cancer cell behaviour
Award winner: Paul Haggarty
Institution: Rowett Research Institute
Value: £146,534
Diet, lifestyle and epigenetics: determinants of breast cancer risk
Award winner: Julia Addington-Hall
Institution: University of Southampton
Value: £209,548
A cohort study of joint pain and stiffness in primary breast cancer
Award winner: Gillian Farnie
Institution: University of Manchester
Value: £459,396
Targeting human breast cancer stem cells to potentiate current DNA damaging therapies
Award winner: Joyce Taylor-Papadimitriou
Institution: King's College London
Value: £14,301
PLU-1/JARID1B and signalling from the ER alpha nuclear receptor.
Award winner: Weiguang Wang
Institution: University of Wolverhampton
Value: £15,000
Targeting Nuclear Factor-kappaB pathway to improve chemotherapy of breast cancer
Award winner: Elinor Sawyer
Institution: King's College London
Value: £15,000 Molecular characterisation of lobular carcinoma in situ.